Anmeldung erfolgt in Kürze...
Details werden geladen...
Ultragenyx Q2 Loss Narrows, Reaffirms 2026 Revenue Outlook | 04.08.26 | finanzen.ch
(RTTNews) - Ultragenyx Pharmaceutical Inc. (RARE) on Tuesday reported a narrower net loss for the second quarter, as revenues grew from a year ago...
Ähnliche Seiten
Ultragenyx Q2 Loss Narrows, Reaffirms 2026 Revenue Outlook | 04.08.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/ultragenyx-q2-loss-narrows-reaffirms-2026-revenue-outlook-1036408976
Snap Q2 Loss Narrows As Revenue Rises 19% | 04.08.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/snap-q2-loss-narrows-as-revenue-rises-19percent-1036402563Snap Q2 Loss Narrows As Revenue Rises 19% | 04.08.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/snap-q2-loss-narrows-as-revenue-rises-19percent-1036402563Corebridge Financial Q2 Net Loss Narrows | 04.08.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/corebridge-financial-q2-net-loss-narrows-1036408963Natera Q2 Loss Narrows As Revenue Jumps; Raises FY26 Revenue Outlook | 06.08.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/natera-q2-loss-narrows-as-revenue-jumps;-raises-fy26-revenue-outlook-1036422816